Today: 20 May 2026
BHP share price faces a Tuesday test as operational review looms and iron ore cools
18 January 2026
1 min read

BHP share price faces a Tuesday test as operational review looms and iron ore cools

Sydney, January 18, 2026, 17:08 AEDT — The market has closed.

BHP Group Ltd shares closed Friday down 0.8% at A$48.99, yet remained roughly 3.5% higher than the previous week, hovering near a 52-week peak ahead of a crucial company update.

As the ASX remains closed over the weekend, focus shifts to Tuesday’s “operational review” — BHP’s routine production and sales report — looking for clues on whether volumes or costs are veering off track ahead of February’s earnings.

This matters since BHP is frequently viewed as a direct play on iron ore and copper, both of which have seen volatile prices. Even a slight shift in output forecasts or unit costs can quickly alter dividend expectations.

Iron ore futures edged lower on Friday, weighed down by soaring prices and squeezed steelmaking margins that dampened demand in China, Reuters reported. The May contract on China’s Dalian Commodity Exchange slipped 0.5%, while Singapore’s key February contract also retreated. Mysteel data revealed iron ore inventories at major Chinese ports climbed to a record high.

Copper, another key driver for global miners, also slipped. The London Metal Exchange’s three-month copper price closed at $12,803 a tonne, falling 2.3% on a day-delayed basis.

Copper prices remain elevated. Reuters Breakingviews reported that prices climbed above $13,000 a tonne on Thursday, driven by pre-tariff stockpiling and supply disruptions at key producers. However, they cautioned these surges may be short-lived. Morgan Stanley strategist Amy Gower highlighted permitting delays that can drag on for more than ten years.

Talk of a deal has added tension. A potential Rio Tinto-Glencore merger might require asset sales to gain China’s green light. “China will see this as an opportunity to squeeze out assets,” said Glyn Lawcock, an analyst at Barrenjoey in Sydney, in comments to Reuters. Mark Kelly, CEO of advisory firm MKI Global Partners, described the deal as “a long, complicated” regulatory battle. Reuters

BHP’s schedule highlights two key dates: the operational review will drop around 8:30 a.m. Melbourne time on January 20, with half-year results set for about 8:00 a.m. on February 17.

But the setup works both ways. Should iron ore continue to drop amid soft steel demand, or if BHP signals rising costs or operational hiccups, the stock could pull back sharply — particularly with prices near recent peaks.

Trading kicks off again Monday, with investors focused first on commodity price shifts. All eyes then turn to Tuesday’s operational review, looking for updates on production, costs, and any shifts in company tone.

Stock Market Today

  • APLD vs. MSFT: Assessing Upside Potential in AI Hosting and Hyperscale Stocks
    May 20, 2026, 5:34 PM EDT. The article compares Applied Digital Corp (APLD) and Microsoft Corp (MSFT) as key players in AI hosting and hyperscale markets. It evaluates growth potential based on current market trends, technological capabilities, and financial performance. Both companies benefit from the surge in artificial intelligence deployment requiring massive data center capacity. MSFT's expansive cloud infrastructure and AI investment contrast with APLD's specialized data center services. Investors should consider market positioning, scalability, and innovation pipelines to assess which stock may offer stronger upside amid rising AI demand.

Latest articles

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

20 May 2026
e.l.f. Beauty forecast fiscal 2027 sales and adjusted profit below Wall Street estimates, citing $15–$20 million in potential oil-related costs from the Iran war. Fourth-quarter net sales rose 35% to $449.3 million, beating expectations, but the company posted a $49.4 million net loss due to a $57.6 million charge tied to the Rhode acquisition. Shares rose after hours despite closing down 4.3% earlier.
Coherent stock swings into Tuesday reopen as analysts cite AI-optics demand, Photonics West
Previous Story

Coherent stock swings into Tuesday reopen as analysts cite AI-optics demand, Photonics West

CBA share price: Commonwealth Bank stock in focus before the RBA call and February earnings
Next Story

CBA share price: Commonwealth Bank stock in focus before the RBA call and February earnings

Go toTop